Cargando…

Risk assessment of venous thromboembolism and bleeding in COVID‐19 patients

BACKGROUND: The coronavirus disease 2019 (COVID‐19) is a newly recognized illness that has spread rapidly all over the world. More and more reports highlight the risk of venous thromboembolism (VTE) in COVID‐19. Our study aims to identify in‐hospital VTE risk and bleeding risk in COVID‐19 patients....

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Lan, Zhao, Lan, Li, Feng, Liu, Ji, Zhang, Li, Li, Qiuhong, Gu, Jin, Liang, Shuo, Zhao, Qinhua, Liu, Jinmin, Xu, Jin‐fu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9060011/ https://www.ncbi.nlm.nih.gov/pubmed/35060325 http://dx.doi.org/10.1111/crj.13467

Ejemplares similares

Bleeding risk assessment for venous thromboembolism prophylaxis
por: Chindamo, Maria Chiara, et al.
Publicado: (2021)

Contrasts in Glioblastoma—Venous Thromboembolism versus Bleeding Risk
por: Muster, Viktoria, et al.
Publicado: (2021)

Assessment of bleeding risk in cancer patients treated with anticoagulants for venous thromboembolic events
por: Poénou, Géraldine, et al.
Publicado: (2023)

Rivaroxaban for cancer-associated venous thromboembolism
por: Liang, Bo, et al.
Publicado: (2021)

Comparison of risk assessments for venous thromboembolism during the puerperium
por: Luo, Xianggui, et al.
Publicado: (2023)

Assessment of the Risk of Venous Thromboembolism in Medical Inpatients using the Padua Prediction Score and Caprini Risk Assessment Model
por: Zhou, Haixia, et al.
Publicado: (2018)

COVID-19–associated venous thromboembolism: risk of recurrence and major bleeding
por: Demelo-Rodriguez, Pablo, et al.
Publicado: (2023)

Biomarkers of bleeding and venous thromboembolism in patients with acute leukemia
por: Hisada, Yohei, et al.
Publicado: (2023)

D-Dimer Measured at Diagnosis of Venous Thromboembolism is Associated with Risk of Major Bleeding
por: Johnsen, Håkon S., et al.
Publicado: (2019)

Bleeding risk in patients with venous thromboembolic events treated with new oral anticoagulants
por: Wallvik, Niklas, et al.
Publicado: (2020)

Recurrent venous thromboembolism and bleeding with extended anticoagulation: the VTE-PREDICT risk score
por: de Winter, Maria A, et al.
Publicado: (2023)

The combination of Caprini risk assessment scale and thrombotic biomarkers to evaluate the risk of venous thromboembolism in critically ill patients
por: Fu, Yang, et al.
Publicado: (2018)

Risk factors for systemic and venous thromboembolism, mortality and bleeding risks in 1125 patients with COVID-19: relationship with anticoagulation status
por: Li, Wencheng, et al.
Publicado: (2021)

Risk assessment and management of preoperative venous thromboembolism following femoral neck fracture
por: Xia, Ze-Nan, et al.
Publicado: (2018)

Comparison of Four Bleeding Risk Scores to Identify Rivaroxaban‐treated Patients With Venous Thromboembolism at Low Risk for Major Bleeding
por: Kline, Jeffrey A., et al.
Publicado: (2016)

Risk of venous thromboembolism in Chinese pregnant women: Hong Kong venous thromboembolism study
por: Huang, Duo, et al.
Publicado: (2019)

Bleeding outcomes in thrombocytopenic acute leukemic patients with venous thromboembolism
por: Wilson, Nathaniel R., et al.
Publicado: (2020)

Evaluation of the predictive value of the bleeding prediction score VTE‐BLEED for recurrent venous thromboembolism
por: Klok, Frederikus A., et al.
Publicado: (2019)

Epidemiology and Risk Assessment of Pediatric Venous Thromboembolism
por: Mahajerin, Arash, et al.
Publicado: (2017)

Impact of oral anticoagulant choice for the secondary prevention of venous thromboembolism on the risk of inpatient bleeding
por: MacLehose, Richard F., et al.
Publicado: (2021)

The Association between Factor XI Deficiency and the Risk of Bleeding, Cardiovascular, and Venous Thromboembolic Events
por: Sharman Moser, Sarah, et al.
Publicado: (2021)

Through thick and thin: Risk of venous thromboembolism vs bleeding after abdominal transplant
por: Whitrock, Jenna N., et al.
Publicado: (2023)

Trajectories of adherence to extended treatment with warfarin and risks of recurrent venous thromboembolism and major bleeding
por: Kang, Hye-Rim, et al.
Publicado: (2023)

Validation of two risk assessment models for venous thromboembolism in patients undergoing gynecologic surgery
por: Guo, Tao, et al.
Publicado: (2022)

Venous thromboembolism risk assessment of surgical patients in Southwest China using real-world data: establishment and evaluation of an improved venous thromboembolism risk model
por: Wang, Peng, et al.
Publicado: (2022)

The Risk of Venous Thromboembolism in Patients with Gallstones
por: Chen, Chien-Hua, et al.
Publicado: (2020)

Correlation between clinicopathological characteristics of lung adenocarcinoma and the risk of venous thromboembolism
por: Zhang, Yuan, et al.
Publicado: (2021)

Prediction of Major Bleeding in Anticoagulated Patients for Venous Thromboembolism: Comparison of the RIETE and the VTE-BLEED Scores
por: Lecumberri, Ramón, et al.
Publicado: (2021)

Risk indicators for venous thrombosis in first-degree relatives of patients with recurrent venous thromboembolism in Chinese
por: Zhao, Lianxing, et al.
Publicado: (2016)

Circulating adipokine concentrations and the risk of venous thromboembolism: A Mendelian randomization and mediation analysis
por: Xiao, Weizhong, et al.
Publicado: (2023)

Impact of a Program to Improve Venous Thromboembolism Prophylaxis on Incidence of Thromboembolism and Bleeding Rates in Hospitalized Patients During Implementation of Programs to Improve Venous Thromboembolism Prophylaxis
por: Lovely, Jenna K., et al.
Publicado: (2020)

An Economic Evaluation of Venous Thromboembolism Prophylaxis Strategies in Critically Ill Trauma Patients at Risk of Bleeding
por: Chiasson, T. Carter, et al.
Publicado: (2009)

Risk Factors of Unfavorable Outcomes, Major Bleeding, and All-Cause Mortality in Patients with Venous Thromboembolism
por: Lee, Han Young, et al.
Publicado: (2021)

Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding
por: Cohen, Alexander T., et al.
Publicado: (2022)

Incidence and risk factors for venous thromboembolism, bleeding, and death in colorectal cancer (Cancer‐VTE Registry)
por: Ikeda, Masataka, et al.
Publicado: (2022)

Bleeding risk in patients with multiple myeloma treated for venous thromboembolism: a MarketScan analysis
por: Adrianzen-Herrera, Diego, et al.
Publicado: (2022)

Effectiveness and Safety of Apixaban vs Warfarin in Patients with Venous Thromboembolism with Risk Factors for Bleeding or for Recurrences
por: Cohen, Alexander T., et al.
Publicado: (2023)

Rivaroxaban versus Apixaban for Treatment of Cancer-Associated Venous Thromboembolism in Patients at Lower Risk of Bleeding
por: Caroti, Kimberly Snow, et al.
Publicado: (2023)

Characterisation and risk assessment of venous thromboembolism in gastrointestinal cancers
por: Metcalf, Robert L, et al.
Publicado: (2017)

Risk of Severe Bleeding With Extended Rivaroxaban to Prevent Venous Thromboembolism in Acute Medically Ill Patients With Bronchiectasis
por: Lipardi, Concetta, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_lg9fkj2d9ndj94ocmnacgqqknm